Pharma Inhouse ApS — Credit Rating and Financial Key Figures

CVR number: 41073098
Mantziusvej 2, 2900 Hellerup
louise@tholstrup.dk
www.pharmainhouse.com

Income statement (kDKK)

2020
2021
2022
2023
Fiscal period length12121212
Net sales
Gross profit1 454.63934.62519.64628.58
Employee benefit expenses-1 078.70-1 044.21- 548.95- 716.22
EBIT375.93- 109.59-29.30-87.64
Other financial expenses-1.72-2.06-2.69-0.29
Pre-tax profit374.20- 111.64-31.99-87.92
Income taxes-82.4824.246.9919.20
Net earnings291.73-87.41-25.00-68.72

Assets (kDKK)

2020
2021
2022
2023
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current trade debtors551.43
Current other receivables76.5521.5723.83
Current deferred tax assets24.2451.2350.43
Short term receivables total551.43100.7972.8074.26
Cash and bank deposits287.9086.12216.33330.35
Cash and cash equivalents287.9086.12216.33330.35
Balance sheet total (assets)839.33186.91289.13404.61

Equity and liabilities (kDKK)

2020
2021
2022
2023
Share capital40.0040.0040.0040.00
Shares repurchased56.5066.00
Other reserves-66.00
Retained earnings-56.50178.7391.320.32
Profit of the financial year291.73-87.41-25.00-68.72
Shareholders equity total331.73131.32106.32-28.40
Non-current liabilities total
Current trade creditors14.0014.0014.0014.00
Short-term deferred tax liabilities82.48
Other non-interest bearing current liabilities411.1241.5843.34155.54
Accruals and deferred income125.46263.47
Current liabilities total507.6055.59182.81433.00
Balance sheet total (liabilities)839.33186.91289.13404.61
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.